Publications by authors named "D Arosio"

Cystic Fibrosis (CF) is a life-shortening autosomal recessive disease caused by mutations in the CFTR gene, resulting in functional impairment of the encoded ion channel. F508del mutation, a trinucleotide deletion, is the most frequent cause of CF affecting approximately 80% of persons with cystic fibrosis (pwCFs). Even though current pharmacological treatments alleviate the F508del-CF disease symptoms there is no definitive cure.

View Article and Find Full Text PDF

Human antigen R (HuR) is an RNA binding protein (RBP) belonging to the ELAV (Embryonic Lethal Abnormal Vision) family, which stabilizes mRNAs and regulates the expression of multiple genes. Its altered expression or localization is related to pathological features such as cancer or inflammation. Dihydrotanshinone I (DHTS I) is a naturally occurring, tetracyclic ortho-quinone inhibitor of the HuR-mRNA interaction.

View Article and Find Full Text PDF
Article Synopsis
  • The RNA binding protein HuR is crucial for regulating the innate immune response, and blocking it can have positive anti-inflammatory outcomes.
  • A new series of small molecules, Tanshinone Mimics (TMs), were developed to disrupt HuR-RNA binding, with furan-containing compound 5/TM11 proving to be the most effective in inhibiting this interaction.
  • Compound 5/TM11 not only enhances solubility but also selectively decreases cell proliferation in macrophages at certain doses, leading to a significant reduction in proinflammatory cytokines in response to LPS.
View Article and Find Full Text PDF

Immunotherapy has emerged as a game-changing approach for cancer treatment. Although monoclonal antibodies (mAbs) targeting the programmed cell death protein 1/programmed cell death protein 1 ligand 1 (PD-1/PD-L1) axis have entered the market revolutionizing the treatment landscape of many cancer types, small molecules, although presenting several advantages including the possibility of oral administration and/or reduced costs, struggled to enter in clinical trials, suffering of water insolubility and/or inadequate potency compared with mAbs. Thus, the search for novel scaffolds for both the design of effective small molecules and possible synergistic strategies is an ongoing field of interest.

View Article and Find Full Text PDF

The objective of this study is to test the feasibility of time-lapse GPR measurements for the quality control of repairing operations (i.e., injections) on marble blocks.

View Article and Find Full Text PDF